Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca(The Medical Center of Aurora), Marc S. Sabatine(Brigham and Women's Hospital), Andrzej Budaj, Deepak L. Bhatt(Mount Sinai Hospital), Róbert Gábor Kiss, Eugene Braunwald(Mass General Brigham), Olof Bengtsson(Copenhagen University Hospital), Giulia Magnani(Brigham and Women's Hospital), Sameer Bansilal(Icahn School of Medicine at Mount Sinai), Shinya Goto(Tokai University), Robert F. Storey(University of Sheffield), Marc Cohen(Newark Beth Israel Medical Center), Ton Oude Ophuis(Canisius-Wilhelmina Ziekenhuis), Christian Hamm(Justus-Liebig-Universität Gießen), Sabina A. Murphy(Brigham and Women's Hospital), KyungAh Im(Brigham and Women's Hospital), Jindřich Špinar(University Hospital Brno), Mikhail Ruda(Institute of Experimental Cardiology), Peter Held(AstraZeneca (Sweden)), Pierre Théroux(Montreal Heart Institute), Stephen Wiviott(Brigham and Women's Hospital), M. Polly Fish(Brigham and Women's Hospital), José Carlos Nicolau(Hospital São Paulo), Eva C. Jensen(AstraZeneca (Sweden)), Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 1,967
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k